Study on clinical, paraclinical and treatment characteristics of stage II to IV nephroblastoma at Children’s Hospital 2
Main Article Content
Abstract
Wilms tumor is the most common pediatric renal malignancy. Local evidence from Vietnam on how neoadjuvant chemotherapy alters imaging risk features and how these changes relate to postoperative histopathology remains limited. to analyze the clinical, paraclinical and treatment characteristics of stage II to IV nephroblastoma at Children’s Hospital 2. A cross-sectional study from April 2013 to June 2016 on 64 cases of stage II - IV nephroblastoma diagnosed and treated with neoadjuvant chemotherapy. 85.7% of tumors are in the age group of 6 months - 5 years. The rate of tumors in males is higher than in females. The rate of tumors in the right kidney is higher than in the left kidney. After preoperative chemotherap, the rate of necrotic tumors increased from 4.7% to 10.9%. The rate of ruptured tumors in response to conservative treatment decreased from 9.4% to 3.2%. The rate of invasive perinephric fat tumors decreased from 85.9% to 43.8%. The rate of vascular invasive tumors decreased from 20.3% to 6.3%, of which the rate of invasive inferior vena cava decreased from 4.7% to 1.6%. The rate of regional lymph node metastasis decreased from 20.3% to 4.7%. The distant metastatic lesions all disappeared. The tumor volume reduced from 487.9cm3 to 206.8cm3 (p < 0.001). Degree of response to preoperative chemotherapy: The overall response rate was 89.1%; the stable or progressive disease was 10.9%. Nephroblastoma is often detected late and has a large volume at the time of diagnosis. Preoperative chemotherapy reduces tumor volume and tumor invasion, facilitating nephrectomy after chemotherapy.
Article Details
Keywords
Nephroblastoma, preoperative chemotherapy, neoadjuvant chemotherapy
References
2. Weirich A, Ludwig R, Graf N, et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol. 2004; 15(5): 808-820.
3. Powis M, Messahel B, Hobson R, et al. Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms’ tumour: findings from the 1991-2001 United Kingdom Children’s Cancer Study Group UKW3 Trial. J Pediatr Surg. 2013; 48(11): 2181-2186.
4. Đặng Hữu Chiến. Đánh giá giai đoạn và nhóm nguy cơ theo SIOP 2001 liên quan thời gian sống còn toàn bộ trong điều trị u Wilms ở trẻ em, Luận văn Bác sĩ chuyên khoa II, Đại học Y Dược TP. Hồ Chí Minh; 2018.
5. Trần Đức Hậu. U nguyên bào thận điều trị tại Bệnh viện Nhi Trung Ương theo phác đồ SIOP 2001. Tạp chí Nhi khoa. 2013; 6(1): 54-59.
6. Mistry R, Manikandan R, Williams P, et al. Implications of computer tomography measurement in the management of renal tumours. BMC Urol. 2008; 8: 13.
7. Olsen ØE, Jeanes AC, Sebire NJ, et al. Changes in computed tomography features following preoperative chemotherapy for nephroblastoma: relation to histopathological classification. Eur Radiol. 2004; 14(6): 990-994. doi: 10.1007/s00330-003-2217-9.
8. Kang H, Lee HY, Lee K, et al. Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts. Korean journal of radiology : official journal of the Korean Radiological Society. 2012; 13:371-390.
9. Pritchard-Jones K, Bergeron C, de Camargo B, et al. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms’ tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015; 386(9999): 1156-1164.
10. Graf N, van Tinteren H, Bergeron C, et al. Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. Eur J Cancer. 2012; 48(17): 3240-3248.
11. Vujanic GM, D’Hooghe E, Popov SD, et al. The effect of preoperative chemotherapy on histological subtyping and staging of Wilms tumors: The United Kingdom Children’s Cancer Study Group (UKCCSG) Wilms tumor trial 3 (UKW3) experience. Pediatr Blood Cancer. 2019; 66(3): e27549.
12. Brisse HJ, Schleiermacher G, Sarnacki S, et al. Preoperative Wilms tumor rupture: a retrospective study of 57 patients. Cancer. 2008; 113(1): 202-213.
13. Lall A, Pritchard-Jones K, Walker J, et al. Wilms’ tumor with intracaval thrombus in the UK Children’s Cancer Study Group UKW3 trial. J Pediatr Surg. 2006; 41(2): 382-387.
14. Irtan S, Van Tinteren H, Graf N, et al. Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial. Eur J Cancer. 2019; 116: 13-20.
15. Reinhard H, Semler O, Burger D, et al. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Klin Padiatr. 2004; 216(3): 132-140.